Viral Hepatitis
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2007; 13(6): 837-844
Published online Feb 14, 2007. doi: 10.3748/wjg.v13.i6.837
Table 6 Diagnostic performance of serum M30-antigen and M65-antigen levels in discriminating NAFLD patients with severe fibrosis from subjects with early fibrosis
Cut-off value1(IU/L)Sensitivity(95% CI) (%)Specificity(95% CI) (%)Positive predictivevalue (%)Negative predictivevalue (%)Negativelikelihood ratioArea under thecurve (95% CI)
M30-antigen121.664.7 (38.4-85.7)77.3 (65.3-86.7)42.3089.500.460.733 (0.624-0.824)
M65-antigen243.8270.6 (44.1-89.6)71.2 (58.7-81.7)38.7090.400.410.742 (0.635-0.832)